On February 28, 2023 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, reported that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor conferences in March (Press release, CytomX Therapeutics, FEB 28, 2023, View Source [SID1234627839]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 43rd Annual Health Care Conference
Date: Tuesday, March 7, 2023
Panel Discussion: 9:10 a.m. ET
Location: Boston, MA

Barclays Global Healthcare Conference
Date: Tuesday, March 14, 2023
Fireside Chat: 4:05 p.m. ET
Location: Miami, FL

Live webcasts of the Cowen panel discussion and Barclays fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.